NCT00020475View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Study Completion Date

March 31, 2007

Conditions
Extraocular Extension MelanomaRecurrent Intraocular Melanoma
Interventions
DRUG

gp100 antigen

DRUG

interleukin-2

DRUG

MART-1 antigen

DRUG

Montanide ISA-51

Trial Locations (1)

20892

Surgery Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020475 - Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye | Biotech Hunter | Biotech Hunter